Synergy CHC Corp (SNYR): Price to Earnings Adjusted for Growth Rate

Symbol and logo of brand Synergy CHC Corp (SNYR)

Synergy CHC Corp (SNYR) relies on decentralized management by delegating operational tasks to third-party partners. Production cycles and delivery are fully outsourced to external contractors, which minimizes internal risks. The portfolio includes resilient wellness brands with high customer loyalty. The growth-weighted P/E demonstrates value dynamics relative to earnings, where 0.00 serves as the current parameter value.

SNYR - Synergy CHC Corp. PEG Multiple over the range 10/24/2024 - 10/03/2026
Mass-produced product of Synergy CHC

Fundamental asset screening begins by identifying undervalued companies through the relationship between valuation and growth rates. This indicator is calculated as the P/E ratio relative to annual earnings growth, as reflected in the PEG ratio history. A value below one signals potential for yield growth. For Synergy CHC Corp (SNYR), this metric confirms the efficiency of its scalable marketing and contract manufacturing model.

Who Synergy CHC Corp competes with

HLN (Haleon PLC) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Kenvue Corp KVUE|Verona Pharma Inc. (VRNA) - Price to Earnings Adjusted for Growth Rate|MENS: Price/Earnings to Growth Multiple|ligand.com - Company Value to Earnings Growth Ratio|AMRX: PEG Multiple|Perrigo Company PLC - Growth-Adjusted Payback Ratio|ALVO (Alvotech Corp) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Liquidia Inc. LQDA|Price/Earnings to Growth Ratio Galapagos NV (GLPG)|ANIP (anipharmaceuticals.com) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio MannKind MNKD|Growth-Adjusted Market Cap to Net Income Amphastar Pharmaceuticals Inc (AMPH)|PCRX: Price/Earnings to Growth Multiple|Price to Earnings Adjusted for Growth Rate ARS Corp|Theravance Biopharma (TBPH) - Price/Earnings to Growth Ratio|Growth-Adjusted P/E Ratio AQST|SCPH (scPharmaceuticals, Inc.) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Tectonic TECX|Price/Earnings to Growth Ratio Tonix Pharmaceuticals Inc. (TNXP)|SXTC (sxtchina.com) - Growth-Adjusted Payback Ratio|PEG Multiple EPRX (Eupraxia Pharmaceuticals Inc.)|Price to Net Income Growth Ratio bioharvest.com|EXOZ: Price/Earnings to Growth Multiple|Price to Earnings Adjusted for Growth Rate Oramed Pharmaceuticals|ENTX (enterabio.com) - Price/Earnings to Growth Multiple|MindWalk Therapeutics - Growth-Adjusted Payback Ratio|ABVC (ABVC BioPharma) - PEG Multiple|Price/Earnings to Growth Multiple cumberlandpharma.com (CPIX)|PEG Multiple QNTM|FGEN (FibroGen Inc) - Growth-Adjusted Payback Ratio|PEG Multiple TELO (Telomir Pharma)|RANI - Price/Earnings to Growth Multiple|RLYB: Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio LEXX (Lexaria Bioscience)|PULM: PEG Multiple|Price/Earnings to Growth Multiple Pheton Holdings|Price/Earnings to Growth Ratio Aptorum Group Ltd|Price to Earnings Adjusted for Growth Rate Lyra Therapeutics Inc LYRA|Price/Earnings to Growth Ratio Impact BioMedical Inc (IBO)|TNFA (tnfpharma.com) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio cbdMD YCBD|PRFX (PainReform Ltd) - Market Cap to Earnings and Growth Ratio|CYTO - Price/Earnings to Growth Ratio|Growth-Adjusted Market Cap to Net Income Lipella Pharma LIPO|OptiNose, Inc. (OPTN) - Price/Earnings to Growth Ratio|Growth-Adjusted P/E Ratio PIRS|Price/Earnings to Growth Multiple PROC|Price to Earnings Adjusted for Growth Rate Petros Pharmaceuticals Inc PTPI|Price/Earnings to Growth Ratio Qilian International Holding Group Limited (QLI)|SLRN (ACELYRIN Inc.) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio TFF Pharmaceuticals TFFP